Dr. Shimon Gross reports

CONFIRMATION OF NO MATERIAL CHANGE

At the request of the Canadian Investment Regulatory Organization, Diagnostear Technologies Inc. has confirmed that the company's management is unaware of any material change in the company's operations that would account for the recent increase in market activity.

About Diagnostear Technologies Inc.

Diagnostear is a global leader in rapid, point-of-care diagnostics for ocular diseases. The company develops multiparametric tests that provide fast, clinically actionable insights based on tear fluid analysis. Diagnostear's mission is to transform ophthalmic care with accessible diagnostics that support precise, data-driven decision making.

We seek Safe Harbor.